Avient (NYSE:AVNT – Get Free Report) is one of 296 public companies in the “Chemicals” industry, but how does it contrast to its competitors? We will compare Avient to similar businesses based on the strength of its institutional ownership, dividends, profitability, analyst recommendations, valuation, risk and earnings.
Insider and Institutional Ownership
95.5% of Avient shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Avient shares are owned by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Avient and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Avient | $3.42 billion | $81.90 million | 23.41 |
| Avient Competitors | $7.96 billion | $229.42 million | 20.18 |
Avient’s competitors have higher revenue and earnings than Avient. Avient is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Avient and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avient | 5.27% | 12.17% | 4.95% |
| Avient Competitors | -54.07% | -0.31% | -1.28% |
Volatility and Risk
Avient has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Avient’s competitors have a beta of 0.94, meaning that their average stock price is 6% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations for Avient and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avient | 0 | 4 | 3 | 0 | 2.43 |
| Avient Competitors | 3272 | 12238 | 14147 | 520 | 2.39 |
Avient presently has a consensus target price of $48.75, indicating a potential upside of 6.79%. As a group, “Chemicals” companies have a potential upside of 6.53%. Given Avient’s stronger consensus rating and higher probable upside, analysts clearly believe Avient is more favorable than its competitors.
Dividends
Avient pays an annual dividend of $1.13 per share and has a dividend yield of 2.5%. Avient pays out 57.9% of its earnings in the form of a dividend. As a group, “Chemicals” companies pay a dividend yield of 3.0% and pay out 101.2% of their earnings in the form of a dividend. Avient has raised its dividend for 1 consecutive years.
Summary
Avient beats its competitors on 9 of the 15 factors compared.
About Avient
Avient Corporation is a global provider of specialty polymer materials, services and solutions. Its offerings include colorants, additives, specialty engineered compounds and other materials designed to enhance the performance, appearance or processing of plastics and other polymers. The company serves customers across industries such as packaging, healthcare, transportation, consumer products and construction. Avient’s products include color and additive concentrates, specialty thermoplastic compounds, and high-performance materials, including advanced fibers and composites.
Receive News & Ratings for Avient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avient and related companies with MarketBeat.com's FREE daily email newsletter.
